Postoperative Pain Management in Patients Undergoing Intramedullary Nail Fixation After Tibia and Femoral Fractures
- Conditions
- Tibial FracturesFemur Fracture
- Interventions
- Other: Use of non-steroid anti-inflammatory drugs (NSAIDS) as an alternative for post-operative pain management after a femur and tibia fractureDrug: Intravenous ketorolac and oral acetaminophenDrug: Intravenous morphine and oral oxycodone
- Registration Number
- NCT04761302
- Lead Sponsor
- University of Puerto Rico
- Brief Summary
The purpose of this trial is to determine whether oral acetaminophen and intravenous ketorolac are viable alternatives to opioid medication regimens for the pain management of patients with tibial and femoral shaft fractures treated with intramedullary nailing. This study will explore an alternative for opioid medications for patients undergoing intramedullary nailing of tibial and femoral shaft fractures.
- Detailed Description
The data analysis for the study will be performed separately for patients with femoral fractures and for patients with tibial fractures. Therefore, the data analysis will compare patients with femoral fractures receiving the experimental treatment to patients with femoral fractures receiving the control treatment (Group 1 vs. Group 2). Likewise, patients with tibial fractures receiving the experimental treatment will be compared to patients with tibial fractures receiving the control treatment (Group 3 vs. Group 4).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 167
- Patients with tibial and femoral shaft fractures
- Patients undergoing intramedullary nailing
- Willing to participate in the protocol
- Chronic pain disorder (daily use of oral opioids)
- Allergy or hypersensitivity to non steroid anti-inflammatory drug
- Impaired renal, cardiac, or hepatic function
- History of gastrointestinal bleeding or substance abuse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group 1: Intravenous Ketorolac and oral acetaminophen Use of non-steroid anti-inflammatory drugs (NSAIDS) as an alternative for post-operative pain management after a femur and tibia fracture Group 1 will be composed of patients receiving the following standard pain control protocol: ketorolac 30 mg intravenous (IV) every 6 hours for patients younger than 70 years versus ketorolac 15 mg IV every 6 hours for patients older than 70 years, first dose will be administered 30 minutes preoperatively. An additional 1000mg of oral acetaminophen will be administered every 6 hours simultaneously regardless of the age group. Patients who determine pain to be unbearable and wish to opt out of the non-opioid group will receive may do so. Group 2: Intravenous Morphine and oral oxycodone Use of non-steroid anti-inflammatory drugs (NSAIDS) as an alternative for post-operative pain management after a femur and tibia fracture Group 2 will be composed of patients receiving the following pain control protocol: morphine 0.1 mg per kg intravenous every 6 hours with an additional oral oxycodone combined with acetaminophen 2 tabs every 6 hours. Group 1: Tibial Fracture Patients Receiving Intravenous Ketorolac and oral acetaminophen Intravenous ketorolac and oral acetaminophen Group 1 will be composed of tibial fracture patients receiving the following standard pain control protocol: ketorolac 30 mg intravenous (IV) every 6 hours for patients younger than 70 years versus ketorolac 15 mg IV every 6 hours for patients older than 70 years, first dose will be administered 30 minutes preoperatively. An additional 1000mg of oral acetaminophen will be administered every 6 hours simultaneously regardless of the age group. Patients who determine pain to be unbearable and wish to opt out of the non-opioid group will receive may do so. Group 2: Tibial Fracture Patients Receiving Intravenous Morphine and oral oxycodone Intravenous morphine and oral oxycodone Group 2 will be composed of tibial fracture patients receiving the following pain control protocol: morphine 0.1 mg per kg intravenous every 6 hours with an additional oral oxycodone combined with acetaminophen 2 tabs every 6 hours. Group 3: Femoral Fracture Patients Receiving Intravenous Ketorolac and Oral Acetaminophen Intravenous ketorolac and oral acetaminophen Group 3 will be composed of femoral fracture patients receiving the following standard pain control protocol: ketorolac 30 mg intravenous (IV) every 6 hours for patients younger than 70 years versus ketorolac 15 mg IV every 6 hours for patients older than 70 years, first dose will be administered 30 minutes preoperatively. An additional 1000mg of oral acetaminophen will be administered every 6 hours simultaneously regardless of the age group. Patients who determine pain to be unbearable and wish to opt out of the non-opioid group will receive may do so. Group 4: Femoral Fracture Patients Receiving Intravenous Morphine and oral oxycodone Intravenous morphine and oral oxycodone Group 4 will be composed of femoral fracture patients receiving the following pain control protocol: morphine 0.1 mg per kg intravenous every 6 hours with an additional oral oxycodone combined with acetaminophen 2 tabs every 6 hours.
- Primary Outcome Measures
Name Time Method 12hrs VAS Pain Scores Measured at postoperative hour 12 Visual Analog Scale; 0-10 (10 indicates highest degree of pain)
24hrs VAS Pain Score Measured at postoperative hour 24 Visual Analog Scale; 0 to 10 (10 indicates highest degree of pain)
36hrs VAS Pain Scores Measured at postoperative hour 36 Visual Analog Scale; 0-10 (10 indicates highest degree of pain)
48hrs VAS Pain Scores Measured at postoperative hour 48 Visual Analog Scale; 0-10 (10 indicates highest degree of pain)
12hrs MME Measured at postoperative hour 12 Opioid consumption at postoperative hour 12. Reported as Morphine Milligram Equivalents (MME)
24hrs MME Measured at postoperative hour 24 Opioid consumption at postoperative hour 24. Reported as Morphine Milligram Equivalents (MME)
36hrs MME Measured at postoperative hour 36 Opioid consumption at postoperative hour 36. Reported as Morphine Milligram Equivalents (MME)
48hrs MME Measured at postoperative hour 48 Opioid consumption at postoperative hour 48. Reported as Morphine Milligram Equivalents (MME)
- Secondary Outcome Measures
Name Time Method Hospital Length of Stay Determined by discharge date Time from intervention to discharge
Trial Locations
- Locations (1)
University District Hospital
🇵🇷San Juan, Puerto Rico
University District Hospital🇵🇷San Juan, Puerto Rico